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Introduction: Medical thoracoscopy is a safe, reliable and therapeutic procedure
used in the management of pleural disease. For reasons that are unclear it is under
utilised in the United Kingdom (UK) when compared to the rest of Europe. We have
studied its development and use over the past 5 years.
Method: We have performed national postal surveys in 1999 and 2004 to assess the
provision of medical thoracoscopy, its indications for use, local practices as well as,
training and audit issues.
Results: 11 centres in 1999 and 17 centres in 2004 perform medical thoracoscopy,
there were more district general hospitals providing this service than teaching
hospitals. Twenty-seven centres in 1999 and 54 centres in 2004 stated plans to begin
providing a service. Centres were performing between 10 and 30 thoracoscopies per
year. There were differences between centres in local practices and training
received. The majority of currently performing centres offered training and were
interested in national audit.
Discussion: This study has shown there are still only a small proportion of UK
respiratory centres performing medical thoracoscopy. There is a growing interest in
the procedure, however, issues regarding standardisation of care across the UK, on
going competency and training have been highlighted. A British Thoracic Society
(BTS) working group has been set up to address these.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Thoracoscopy allows direct examination of the
pleural cavity, it has been shown that it can be
performed under sedation and local anaesthesiaElsevier Ltd. All rights reserve
9503037
rg.uk (N.J. Burrows).by respiratory physicians and in this context is
called ‘‘Medical Thoracoscopy’’. Medical thoraco-
scopy is usually performed through a single port,
as part of the investigation of an undiagnosed
pleural effusion. Direct vision pleural biopsies
sampled by this method have a diagnostic effi-
ciency of about 95%.1,2 Medical thoracoscopy also
has the therapeutic benefits of pleural fluidd.
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rates of 490%.3 It is a safe procedure with low
morbidity and mortality rates.4 The procedure is
widely used in Europe, but the reasons for its
limited use and slow uptake by United Kingdom
respiratory physicians remain unclear.5 Here we
present the results of two surveys carried out to
quantify the provision and development of this
service over the past 5 years.Method
In 1999 and 2004 a postal survey was sent to all of
the 250 Respiratory Centres identified in the BTS
directory. Questions were included on provision of
service, indications for use, local procedure prac-
tices as well as training and audit. The question-
naire is shown in the text box. The data was
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In 1999 we had replies from 196 (78%) centres and
in 2004, 207 (82%) of centres responded.30 72
Figure 2 The number of thoracoscopies performed per
annum by each centre in 1999 and 2004.
No. Of Physicians in
1999
No. Of Physicians in
2004
Local Training 6 (54%) 5 (29%)
Surgical Training 5 (27%) 3 (18%)
International Course 2 (18%) 9 (53%)
Figure 3 Where training has been recieved by medical
thoracoscopists in 1999 and 2004.Provision of medical thoracoscopy
In 1999, 11 (4.4%) centres in the UK provided a
medical thoracascopy service and 27 stated definite
plans to commence a service. In 2004, 17 (6.8%)
centres report performing the procedure and 54
stated plans to commence a service within 5 years
(28 within the next year). In 1999, 9 of the centres
were district general hospitals and 2 were Teaching
Hospitals both of which had thoracic surgery on
site. In 2004, 11 centres were district general
hospitals and 6 were teaching hospitals, 5 had
thoracic surgery on site. Figure 1 shows the
regional distribution of centres providing medical
thoracoscopy in the UK in 2004. Each centre in the
UK performs between 10 and 30 medical thoracos-
copies per annum as shown in Fig. 2. In 2004 12/17
centres had encountered no major problems in
setting up their thoracoscopy service. 2/17 had
problems with access to theatres or the endoscopy
suite and 3/17 had problems with funding for
equipment and training.Figure 1 The number of centres by region in 2004
performing medical thoracoscopy.Indications for use
The main indication in both surveys for medical
thoracoscopy was in the investigation of a pleural
effusion. In 1999, 8/11 (66%) of centres perform
talc pleurodesis compared to 13/17 (76%) in 2004.
In 1999 no centres were performing more advanced
techniques, by 2004, 3 centres used medical
thoracoscopy to biopsy a pleural mass without an
effusion and to treat pneumothoraces.Local procedure practices
In both 1999 and 2004 medical thoracoscopies were
carried out in the endoscopy suite, 6/11 and 11/17,
respectively. Others sites used in both surveys were
operating theatres and rooms attached to the
ward. All centres in both surveys carried out
medical thoracoscopy under local anaesthetic and
sedation. No centres in 1999 and only 2 centres in
2004 routinely used prophylactic antibiotics. (Both
of these centres introduced antibiotics after
instances of post procedure empyema.) In 2004,
11/17 centres aimed to discharge patients home
the day after the procedure, 6 centres stated they
often keep patients for a longer period of time.Previous training received
In both 1999 and 2004, respiratory physicians had
either been trained locally by other medical or
surgical thoracoscopists (Fig. 3). However, a sig-
nificant proportion of UK physicians had attended
training courses in France.
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In 1999, 5/11 centres offered training to specialist
registrars in medical thoracoscopy compared to 13/
17 (76%) centres in 2004. In both 1999 and 2004, of
the centres that offered training, the number of
procedures required for competence was stated as
between 10 and 50 procedures, however, 3/5 and
6/13 centres, respectively, were undecided. In
2004, 13/17 centres undertook regular audit of
the service. 16/17 centres thought a national audit
of practice would be a good idea and 12/17 would
be interested in taking part.
Future trends
In 1999, 27 centres stated definite plans to develop
a medical thoracoscopy service in their hospital this
number had increased to 54 by 2004; 28 within the
next 12 months and the rest within 5 years. In 1999,
32 centres thought it was important for Respiratory
Physicians to provide a medical thoracoscopy
service but currently have no plans to start a
service; this number was 71 in 2004 (Fig. 4).Discussion
These surveys have shown that medical thoraco-
scopy is only provided by a small percentage of
respiratory centres in the UK and its development
has been slow over the past 5 years. The predicted
number of 40 centres providing a service by 2004
has not been reached; the definite reasons for this
remain unclear. In our survey, the 5 centres that
had experienced problems in setting up their
service found; access to an area to perform the
procedure and lack of funding for training and
equipment to be the main hurdles. Further re-
search into this area is needed to identify all the
problem areas and ways to improve them.
Despite these problems the number of centres























Figure 4 The number of centres performing, with plans
to start performing and interested in medical thoraco-
scopy in 1999 and 2004.increased and there is growing interest and aware-
ness in the procedure (Fig. 4). We suggest the
reasons for this include; firstly an increasing
incidence of mesothelioma in the UK, which by
2020 is predicted to be 3000 cases per year6 and in
which there is renewed interest in potential
therapies. Secondly, in light of the Calman–Hine
report more emphasis has been placed on rapid
diagnosis and treatment of thoracic malignancy.7
(The Calman–Hine report was produced in 1995 to
standardise cancer care in England and Wales, it
highlighted early diagnosis and treatment by a
multidisciplinary team as a key factor along with
cancer registration and monitoring of outcomes.)
Overall there are a greater number of district
general hospitals providing a medical thoracoscopy
service compared to teaching hospitals, which
probably reflects poor access to thoracic surgery
facilities in these hospitals. However, the most
recent centres to develop a service in our survey
are teaching hospitals with thoracic surgery on site
suggesting that there is a need for both medical and
surgical thoracoscopy in the same unit. The newer
centres are performing less thoracoscopies per year
than the more established ones. With more than
half of the centres performing less than 20
procedures per year there are standard of care
and on going competency issues.
The survey in 1999 found physicians were trained
by local expertise but more recently international
courses, mainly in France, have been popular. One
problem identified from this survey was lack of
funding for training. The introduction of a UK
thoracoscopy course in 2004 has improved oppor-
tunities for training in this country and therefore,
decreased financial costs.
The main indications for using thoracoscopy
across the UK are standard, however, centres with
increased experience are performing more techni-
cally challenging procedures. Local procedural
practice appears to be similar but small differences
are present between centres, which suggest a need
for further research, and national guidelines to
standardise best practice.
The majority of centres performing the proce-
dure are involved in training specialist registrars,
however, with the wide discrepancy in provision of
medical thoracoscopy service the level of experi-
ence any individual specialist registrar may receive
is variable. The specialist registrar training scheme
gives limited advice on assessing competency in this
field. This was reflected in the wide variation in
number of thoracoscopies that physicians felt
should be completed before an assessment of
competency can be made. For comparison the
British Thoracic Society (BTS) guidelines state 100
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indirectly supervised) should be completed before
competency is implied.8 With the current numbers
of medical thoracoscopy being performed matching
these levels is unrealistic and this raises important
training issues.
These surveys are the only data available on the
use of medical thoracoscopy in the UK, we achieved
good response rates and therefore, this reflects the
current situation. However, the data is subjective,
based on individual clinicians records and we did
not make attempts to validate this further. This
study has shown a slow uptake of medical thoraco-
scopy in the UK, further studies to identify reasons
for this would be useful to help improve service
development.
This study has shown the provision of medical
thoracoscopy in the UK to be lacking at the current
time and that centres have been slow in initiating
services. However, it is encouraging to find there is
increasing use and interest among UK respiratory
physicians and that centres are finding a need to
provide both medical and surgical thoracoscopy.
This survey has highlighted a need for increased
awareness of the procedure and a need to develop
medical thoracoscopy across the UK, as this will
help standardise pleural effusion management. To
address these issues a BTS working party has been
developed and recommendations are in the process
of being produced. These will include advice on
how to set up and run a medical thoracoscopyservice as well as guidance on training and
competency assessment.Acknowledgements
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